CCH is now offering the innovative Jada® System to treat postpartum hemorrhage
3/30/2021
-mid.jpg)
In November 2020, Columbus Community Hospital became the first hospital in the state and one of the first 10 hospitals in the country to offer the Jada® System, a cutting-edge technology to address postpartum hemorrhage.
Postpartum hemorrhage and maternal mortality are growing problems in the United States.
According to the Centers for Disease Control and Prevention (CDC) about 700 women in the United States die each year because of pregnancy or delivery complications. Deaths that occur during delivery are most commonly caused by obstetric emergencies, such as postpartum hemorrhage.
Mothers welcoming babies at CCH will now have the option to be treated with Jada® in the event that they experience abnormal uterine bleeding or hemorrhage after delivery.
“Bleeding, while not uncommon after delivery, can become life-threatening if it is left untreated,” said Kimberly Eisenmann, RN, BSN, director of maternal child health at CCH, “Jada® is a tool that can help us manage and control bleeding before it becomes life-threatening or leads to other complications in the mother’s recovery.”
The Jada® System, from Alydia Health, is made of medical-grade silicone and is designed to be soft. It is placed in the uterus and gentle suction is applied. This action removes blood and induces the uterus to contract and stop bleeding, as it should naturally do after childbirth. In many cases, bleeding is controlled in as little as three minutes, which allows mothers to spend more time bonding with their babies.
“The Jada® device is easy to use and very effective in controlling bleeding,” said Eisenmann. “It adds an additional tactic physicians and staff can use to prevent maternal hemorrhage and decrease maternal mortality which is a concern in any labor and delivery across the United States.”
The Jada® System is proven to control hemorrhages within minutes. Other devices available to treat postpartum hemorrhage require 12 to 24 hours of balloon pressure inside the uterus, and pharmaceutical treatments are associated with side effects that can also interrupt maternal bonding.
Other benefits of Jada® include its potential to:
- Reduce the length of stay for mothers on the labor and delivery floor or in the intensive care unit
- Create a faster mother-to-baby bonding time
- Reduce the need for blood transfusions
- Reduce the overall costs associated with longer hospital stays for mothers
- Allow mothers to avoid the stress/trauma they might experience after having been through a postpartum hemorrhage situation
The Cleveland Clinic, one of largest hospitals in the country, named devices like Jada®, one of its “Top 10 Medical Innovations of the Year” for 2021.
“Jada® is new, cutting-edge technology,” Eisenmann said. “Our obstetric physicians brought this to us to improve the outcomes for our patients and the hospital leadership supported this. We are so very fortunate to have this as an option for our patients that are facing potential complications following delivery.”
For more on how CCH’s maternal child health department is offering the best care to mothers and their babies, visit their department’s page
here.